Cargando…

Negative outcome Charles Bonnet Syndrome

BACKGROUND: Charles Bonnet Syndrome (CBS) is widely considered a transient condition without adverse consequence, questioning the need for treatment. Yet, while this view may be true of the majority of people with CBS, it is recognised that some have negative experiences and outcomes. Here, we attem...

Descripción completa

Detalles Bibliográficos
Autores principales: Cox, Thomas M, ffytche, Dominic H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145458/
https://www.ncbi.nlm.nih.gov/pubmed/24825847
http://dx.doi.org/10.1136/bjophthalmol-2014-304920
_version_ 1782332182474260480
author Cox, Thomas M
ffytche, Dominic H
author_facet Cox, Thomas M
ffytche, Dominic H
author_sort Cox, Thomas M
collection PubMed
description BACKGROUND: Charles Bonnet Syndrome (CBS) is widely considered a transient condition without adverse consequence, questioning the need for treatment. Yet, while this view may be true of the majority of people with CBS, it is recognised that some have negative experiences and outcomes. Here, we attempt to better understand negative outcome CBS and the factors that influence it. METHODS: 4000 members of the Macular Society were sent a structured questionnaire covering the phenomenology of CBS, its prognosis and impact, symptom reporting, patient knowledge and sources of information. RESULTS: 492 people with CBS were identified. Kaplan–Meier analysis suggested 75% had CBS for 5 years or more. Thirty-two per cent had negative outcome. Factors associated with negative outcome were: (1) frequent, fear-inducing, longer-lasting hallucination episodes, (2) one or more daily activities affected, (3) attribution of hallucinations to serious mental illness, (4) not knowing about CBS at the onset of symptoms. Duration of CBS or the type of content hallucinated were not associated with negative outcome. CONCLUSIONS: CBS is of longer duration than previously suspected with clinically relevant consequences in a third of those affected. Interventions that reduce the frequency, duration or fear of individual hallucination episodes and education prior to hallucination onset may help reduce negative outcome.
format Online
Article
Text
id pubmed-4145458
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-41454582014-09-02 Negative outcome Charles Bonnet Syndrome Cox, Thomas M ffytche, Dominic H Br J Ophthalmol Clinical Science BACKGROUND: Charles Bonnet Syndrome (CBS) is widely considered a transient condition without adverse consequence, questioning the need for treatment. Yet, while this view may be true of the majority of people with CBS, it is recognised that some have negative experiences and outcomes. Here, we attempt to better understand negative outcome CBS and the factors that influence it. METHODS: 4000 members of the Macular Society were sent a structured questionnaire covering the phenomenology of CBS, its prognosis and impact, symptom reporting, patient knowledge and sources of information. RESULTS: 492 people with CBS were identified. Kaplan–Meier analysis suggested 75% had CBS for 5 years or more. Thirty-two per cent had negative outcome. Factors associated with negative outcome were: (1) frequent, fear-inducing, longer-lasting hallucination episodes, (2) one or more daily activities affected, (3) attribution of hallucinations to serious mental illness, (4) not knowing about CBS at the onset of symptoms. Duration of CBS or the type of content hallucinated were not associated with negative outcome. CONCLUSIONS: CBS is of longer duration than previously suspected with clinically relevant consequences in a third of those affected. Interventions that reduce the frequency, duration or fear of individual hallucination episodes and education prior to hallucination onset may help reduce negative outcome. BMJ Publishing Group 2014-09 2014-05-14 /pmc/articles/PMC4145458/ /pubmed/24825847 http://dx.doi.org/10.1136/bjophthalmol-2014-304920 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Clinical Science
Cox, Thomas M
ffytche, Dominic H
Negative outcome Charles Bonnet Syndrome
title Negative outcome Charles Bonnet Syndrome
title_full Negative outcome Charles Bonnet Syndrome
title_fullStr Negative outcome Charles Bonnet Syndrome
title_full_unstemmed Negative outcome Charles Bonnet Syndrome
title_short Negative outcome Charles Bonnet Syndrome
title_sort negative outcome charles bonnet syndrome
topic Clinical Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145458/
https://www.ncbi.nlm.nih.gov/pubmed/24825847
http://dx.doi.org/10.1136/bjophthalmol-2014-304920
work_keys_str_mv AT coxthomasm negativeoutcomecharlesbonnetsyndrome
AT ffytchedominich negativeoutcomecharlesbonnetsyndrome